ClinicalTrials.gg
CompletedNCT03372369Updated Aug 20, 2019Results posted

Testing the Impact of Two Posters on Contraceptive Knowledge, Contraceptive Preferences, and Perceived Pregnancy Risk

An interventional study of View CDC Poster and View Patient-Centered Poster in Contraception and Knowledge, Attitudes, Practice, sponsored by University of North Carolina, Chapel Hill. Completed at 1 site in United States. Open to female participants aged 18 Years to 44 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2019-08-20.

Sponsored by University of North Carolina, Chapel Hill · Not applicable, Interventional, and Prevention

Phase
Not applicable
Study type
Interventional
Enrollment
990
Allocation
Randomized
Ages
18 Years to 44 Years
Sex
Female
01

Study summary

This study tests two posters that teach people about contraception: one designed by the Centers for Disease Control (CDC), and one designed by the researchers. The investigators hypothesize that the new poster will have more increased (1) contraceptive knowledge, (2) willingness to use effective contraception, and (3) perceived pregnancy risk than the CDC poster. This study will expand useful knowledge because contraceptive knowledge, willingness to use effective contraception, and perceived pregnancy risk have been shown to affect women's likelihood of using contraception. If the investigators learn how to increase these factors, the investigators could theoretically reduce women's risk of unplanned pregnancy.

The investigators will test this hypothesis by recruiting N=1000 women to complete an online survey using Amazon Mechanical Turk. These women will complete a survey that will first measure their initial contraceptive knowledge, willingness to use effective contraception, and perceived pregnancy risk. Then women will randomly be shown one of the two posters. Then, the investigators will measure their contraceptive knowledge, willingness to use effective contraception, and perceived pregnancy risk again. The investigators will use statistical tests (a t-test) to find out whether there are significant changes in these three outcomes for either of the posters, and whether one poster does a better job of changing these outcomes than the other.

Read the detailed description

Purpose: To evaluate the effectiveness of two posters' ability to improve contraceptive knowledge, willingness to use effective contraception, and pregnancy risk perceptions. One of these posters was developed by the CDC. The other was developed by the research team in a previous study using cognitive interviews with N=26 women. The new poster is designed to meet the informational needs of women with low numeracy (i.e. low facility with math) and women who do not use contraception.

Participants: The investigators will recruit N=1020 women aged 18-44 who can speak and read English, have been sexually active in the last three months, and who are not pregnant or trying to get pregnant.

Procedures (methods): The investigators will use Amazon Mechanical Turk to recruit participants. Participants will take one survey. The survey will first ask baseline questions to assess contraceptive knowledge, willingness to use effective contraception, and perceived pregnancy risk. Participants will then be randomly shown one of the two posters. Then post-exposure questions on the three outcomes will be asked.

The investigators test the hypotheses that before compared to after exposure, the mean scores for (1) contraceptive knowledge, (2) willingness to use effective contraception, and (3) perceived pregnancy risk will increase more for the new fact sheet than for the CDC sheet.

The investigators also collect the following covariates: age, race/ethnicity, education, income, insurance type, insurance coverage of contraception, numeracy (facility with math), health and safety contraindications to contraceptive use, sexual orientation, parenthood, years since first sex, relationship status, prior exposure to CDC sheet, and pregnancy avoidance intensity. The investigators will compare whether the covariates are balanced between the randomized groups and the US population using two-sample t-tests, chi-squared, or nonparametric tests as appropriate. If the unbalance is statistically significant, the investigators will include the covariate in the regression to compare the adjusted difference between treatments. The investigators use two-sample t-tests to test our hypotheses. The investigators will also test for subgroup differences in our outcomes based on our covariates using a Chow test.

The investigators will first test survey mechanics (correct coding, correct links) on N=20 women. The investigators will survey N=1000 women for data analysis.

02

Conditions studied

  • Contraception
  • Knowledge, Attitudes, Practice

Browse trials for

Keywords

  • contraceptive knowledge
  • contraceptive use
  • educational intervention
  • poster
  • online survey
03

In context

Behavior

1,573 studies on the registry are indexed under Behavior; 313 are open to participants now.

This study's enrollment of 990 is above the median of 120 across 1,197 interventional studies indexed under Behavior.

Browse Behavior studies →

Lead sponsor

University of North Carolina, Chapel Hill is the lead sponsor of 1,372 studies on the registry; 133 are open to participants now.

Of its 161 completed or terminated interventional studies of FDA-regulated products, 139 (86%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 44 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Speak and read English
  • Have had vaginal intercourse in the past three months

Exclusion criteria

Exclusion Criteria:

  • Are pregnant
  • Are trying to conceive
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
990 participants (actual)

Study arms

  • Active comparator
    CDC Poster

    After collecting baseline contraceptive knowledge, method preference, if participant were to switch methods during the next year, and current perceived pregnancy risk, participants will view CDC poster for contraceptive effectiveness.

    Other: View CDC Poster

  • Experimental
    Patient-Centered Poster

    After collecting baseline contraceptive knowledge, method preference, if participant were to switch methods during the next year, and current perceived pregnancy risk, participants will view Patient-Centered poster for contraceptive effectiveness.

    Other: View Patient-Centered Poster

Interventions

  • OtherView CDC Poster

    The poster designed by the CDC to explain contraceptive effectiveness.

  • OtherView Patient-Centered Poster

    The poster designed by the research team to explain contraceptive effectiveness. This poster was developed through cognitive interviews with 26 North Carolina women, and the final version of this poster was found to be more useful, acceptable, and attractive than the CDC poster by the majority of women participating.

06

What researchers measure

Primary outcomes

  1. Change in Contraceptive Knowledge Assessment (CKA) Score

    The CKA is a 25-item tool covering knowledge gaps like long-acting reversible contraceptives, emergency contraception, common myths, and efficacy rates which will be used to determine contraception knowledge. One point is added for each correctly answered question for a total possible score of 25. Higher scores reflect greater contraceptive knowledge.

    Time frame: Baseline and 15-20 minutes after baseline (3 minutes after exposure to a poster)

  2. Change in Effective Contraception Preference Score

    Women will be asked whether they are planning on switching contraceptive methods in the next year and which methods of contraception they would hypothetically consider using if they were to switch contraceptive methods within the next year. They are then asked to rank the methods in order of how likely they would be to use each method. A woman's "contraceptive preference" is the method that she says she would be most likely to use. Methods will be scored from 0-3: '0' for no method, '1' for ineffective methods like condoms, '2' for effective methods like the Pill, and '3' for highly effective methods like Intrauterine Devices (IUDs). Positive scores reflect improvements in the effectiveness of the contraceptive method that women say they are likely to use.

    Time frame: Baseline and 15-20 minutes after baseline (1 minute after exposure to a poster)

  3. Change in Perceived Pregnancy Risk Score

    Women are asked what their chances of getting pregnant this year are (very high=4, high=3, moderate=2, low=1, very low=0). A good outcome in terms of reducing the risk of unprotected sex and unplanned pregnancy would be increased perceived pregnancy risk as reflected in a higher score.

    Time frame: Baseline and 15-20 minutes after baseline (2 minutes after exposure to a poster)

07

Results

Posted Jun 7, 2019
Limitations and caveats
Results are likely only generalizable to US female internet users. The study does not assess the impact of the posters on behavior, only intentions.

Participant flow

Participants were enrolled between January 26 and February 13, 2018. They were enrolled and participated in the study through a survey distributed on Amazon Mechanical Turk.

Qualification Period
Participant flow — Qualification Period
MilestoneCDC PosterPatient-Centered Poster
Started495495
Completed469473
Not completed2622
Withdrew: Withdrawal by subject1613
Withdrew: Inconsistent eligibility results109
Intervention and Follow-Up Period
Participant flow — Intervention and Follow-Up Period
MilestoneCDC PosterPatient-Centered Poster
Started469473
Completed466470
Not completed33
Withdrew: Withdrawal by subject33

Outcome measures

PrimaryChange in Contraceptive Knowledge Assessment (CKA) Score

The CKA is a 25-item tool covering knowledge gaps like long-acting reversible contraceptives, emergency contraception, common myths, and efficacy rates which will be used to determine contraception knowledge. One point is added for each correctly answered question for a total possible score of 25. Higher scores reflect greater contraceptive knowledge.

Time frame:
Baseline and 15-20 minutes after baseline (3 minutes after exposure to a poster)
Reported as:
Mean · scores on a scale
Change in Contraceptive Knowledge Assessment (CKA) Score
scores on a scaleCDC PosterPatient-Centered Poster
Change in Contraceptive Knowledge Assessment (CKA) Score0.90 (0.66 to 1.13)1.6 (1.31 to 1.90)
Statistical analysis
  • CDC Poster · t-test, 1 sided · p = <0.0001 (The Bonferroni correction is used to account for multiple comparisons. In this analysis, p\<0.01 is the threshold for statistical significance.)
  • Patient-Centered Poster · t-test, 1 sided · p = <0.0001 (The Bonferroni correction is used to account for multiple comparisons. In this analysis, p\<0.01 is the threshold for statistical significance.)
  • CDC Poster vs Patient-Centered Poster · t-test, 1 sided · p = <0.0001 (The Bonferroni correction is used to account for multiple comparisons. In this analysis, p\<0.01 is the threshold for statistical significance.)
PrimaryChange in Effective Contraception Preference Score

Women will be asked whether they are planning on switching contraceptive methods in the next year and which methods of contraception they would hypothetically consider using if they were to switch contraceptive methods within the next year. They are then asked to rank the methods in order of how likely they would be to use each method. A woman's "contraceptive preference" is the method that she says she would be most likely to use. Methods will be scored from 0-3: '0' for no method, '1' for ineffective methods like condoms, '2' for effective methods like the Pill, and '3' for highly effective methods like Intrauterine Devices (IUDs). Positive scores reflect improvements in the effectiveness of the contraceptive method that women say they are likely to use.

Time frame:
Baseline and 15-20 minutes after baseline (1 minute after exposure to a poster)
Reported as:
Mean · scores on a scale
Change in Effective Contraception Preference Score
scores on a scaleCDC PosterPatient-Centered Poster
Change in Effective Contraception Preference Score0.09 (0.02 to 0.17)0.09 (0.01 to 0.17)
Statistical analysis
  • CDC Poster · t-test, 1 sided · p = <0.001 (The Bonferroni correction is used to account for multiple comparisons. In this analysis, p\<0.01 is the threshold for statistical significance.)
  • Patient-Centered Poster · t-test, 1 sided · p = <0.01 (The Bonferroni correction is used to account for multiple comparisons. In this analysis, p\<0.01 is the threshold for statistical significance.)
  • CDC Poster vs Patient-Centered Poster · t-test, 1 sided · p = >0.01 (The Bonferroni correction is used to account for multiple comparisons. In this analysis, p\<0.01 is the threshold for statistical significance.)
PrimaryChange in Perceived Pregnancy Risk Score

Women are asked what their chances of getting pregnant this year are (very high=4, high=3, moderate=2, low=1, very low=0). A good outcome in terms of reducing the risk of unprotected sex and unplanned pregnancy would be increased perceived pregnancy risk as reflected in a higher score.

Time frame:
Baseline and 15-20 minutes after baseline (2 minutes after exposure to a poster)
Reported as:
Mean · scores on a scale
Change in Perceived Pregnancy Risk Score
scores on a scaleCDC PosterPatient-Centered Poster
Change in Perceived Pregnancy Risk Score0.002 (-0.06 to 0.06)0.03 (-0.03 to 0.09)
Statistical analysis
  • CDC Poster · t-test, 1 sided · p = >0.01 (The Bonferroni correction is used to account for multiple comparisons. In this analysis, p\<0.01 is the threshold for statistical significance.)
  • Patient-Centered Poster · t-test, 1 sided · p = >0.01 (The Bonferroni correction is used to account for multiple comparisons. In this analysis, p\<0.01 is the threshold for statistical significance.)
  • CDC Poster vs Patient-Centered Poster · t-test, 1 sided · p = >0.01 (The Bonferroni correction is used to account for multiple comparisons. In this analysis, p\<0.01 is the threshold for statistical significance.)
Post-hocChange in Mean Accuracy of Perceived Pregnancy Risk Score

Women are asked what their chances of getting pregnant this year are (very high, high, moderate, low, very low). This response is compared to the most effective contraceptive method women reported using in the past three months using the same categories of effectiveness as in the "change in effective contraception preference score" outcome. Women received a score of 1 if their perceived pregnancy risk was accurate based on their current contraceptive method and a score of 0 if it was inaccurate. Women's perceived pregnancy risk was accurate if: they used a highly effective method and they said they were at very low risk; if they used an effective method and they said they were at low or moderate risk; if they used a less effective method and said they were at moderate or high risk; or if they used no method and said they were at very high risk. A good outcome would be increased accuracy of perceived pregnancy risk as reflected by a higher score.

Time frame:
Baseline and 15-20 minutes after baseline (2 minutes after exposure to a poster)
Reported as:
Mean · scores on a scale
Change in Mean Accuracy of Perceived Pregnancy Risk Score
scores on a scaleCDC PosterPatient-Centered Poster
Change in Mean Accuracy of Perceived Pregnancy Risk Score0 (-0.02 to 0.02)0.013 (-0.01 to 0.04)
Statistical analysis
  • CDC Poster · t-test, 1 sided · p = >0.01 (The Bonferroni correction is used to account for multiple comparisons. In this analysis, p\<0.01 is the threshold for statistical significance.)
  • Patient-Centered Poster · t-test, 1 sided · p = >0.01 (The Bonferroni correction is used to account for multiple comparisons. In this analysis, p\<0.01 is the threshold for statistical significance.)
  • CDC Poster vs Patient-Centered Poster · t-test, 1 sided · p = >0.01 (The Bonferroni correction is used to account for multiple comparisons. In this analysis, p\<0.01 is the threshold for statistical significance.)

Adverse events

Collected over Participants could report adverse events from the time they began the study survey through survey completion; up to 2 hours.. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
CDC Poster0/495 (0%)0/495 (0%)0/495 (0%)
Patient-Centered Poster0/495 (0%)0/495 (0%)0/495 (0%)

Baseline characteristics

Baseline data is reported for participants completing the qualification phase.

Age, Continuous
Age, Continuous(years)CDC PosterPatient-Centered PosterTotal
Mean32 (18 to 44)32 (18 to 44)32 (18 to 44)
Sex: Female, Male
Sex: Female, Male(Participants)CDC PosterPatient-Centered PosterTotal
Female469473942
Male000
Race/Ethnicity, Customized
Race/Ethnicity, Customized(Participants)CDC PosterPatient-Centered PosterTotal
Race or Ethnicity — White353351704
Race or Ethnicity — Black or African American453681
Race or Ethnicity — Hispanic or Latina172138
Race or Ethnicity — Some Other Race283462
Race or Ethnicity — Multiracial263157
Region of Enrollment
Region of Enrollment(Participants)CDC PosterPatient-Centered PosterTotal
United States469473942
08

Study locations

1 site
  • University of North Carolina at Chapel Hill
    Chapel Hill, North Carolina 27510, United States
09

References and documents

Publications

  • Anderson S, Frerichs L, Kaysin A, Wheeler SB, Halpern CT, Lich KH. Effects of Two Educational Posters on Contraceptive Knowledge and Intentions: A Randomized Controlled Trial. Obstet Gynecol. 2019 Jan;133(1):53-62. doi: 10.1097/AOG.0000000000003012. PubMed 30531560 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No — No sharing of individual participant data with other researchers

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 20, 2019, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT03372369
Collaborators
North Carolina Translational and Clinical Sciences Institute
Responsible party
Sponsor
First posted
Dec 13, 2017
Start date
Jan 26, 2018
Primary completion
Feb 13, 2018
Completion
Feb 13, 2018
Results posted
Jun 7, 2019
Last update
Aug 20, 2019

Study contacts

Seri AL Anderson, MPH
principal investigator · University of North Carolina, Chapel Hill
Kristen H Lich, PHD
principal investigator · University of North Carolina, Chapel Hill

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion